Advertisement Advertisement Advertisement
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Susan Hasty, Publisher Table of Contents . . . May 14th, 2003 Non-Subscriber - Summaries Only Related Areas: Other Issues in Biotech Week | Other Publications
Copernicus Therapeutics - Sustained release of DNA achieved with lipid microtubules and agarose hydrogelCordis Corp. - FDA approves drug-coated stentsBoston Scientific, Inc. - FDA approves implantGenzyme Corp. - FDA approves first treatmentNeurocrine Biosciences - Patent issued for proprietary compound for treatment of insomniaUniversity of Pittsburgh - Noninvasive glucose sensor will be worn as a contact lensAastrom Biosciences, Inc. - Collaboration agreement signed for German bone graft clinical trialAcadia Pharmaceuticals - Drug discovery alliance focused on eye care applicationsActivBiotics, Inc. - Mekalanos named to scientific advisory boardAdolor Corporation - Schied retires as chief financial officerAdvanced Magnetics, Inc. - Imaging agent maker reports net loss of $0.10 per shareAlcon, Inc., - New cataract removal system debuted; conjunctivitis drug approvedAlnylam Pharmaceuticals, Inc. - Therapeutic RNA interference company says senior management team expandedAlparslan Mah Kyzylyrmak Cad - Color Doppler imaging can quantify contraction at the tip of the LAAAlpharma, Inc. - Pharma company's senior notes due in 2011 sold in private placementAlthea Technologies, Inc. - Gene company expands to new headquarters, gets NIH contractAmerican Oriental Bioengineering - Chinese biotech company reports $1.1M profitAntares Pharma, Inc. - Trial of needle-free drug delivery system beginsAnthem, Inc. - Pharmaceutical company raises 2003 outlookArQule, Inc. - Biotech company reports net loss of $0.03 per shareBarr Laboratories, Inc. - Approval granted for generic AccutaneBaxter International, Inc. - Sales grew 6% while earnings declined for pharma companyBioSeek, Inc. - Sigal added to scientific advisory boardBiogen, Inc. - Revenues increase 11% in first quarter for biotech companyBiomerica, Inc. - Net loss reported at $0.00 for biotech companyBiosyntrx - Ophthalmic company announces new board member, start of new trialBristol-Myers Squibb Company - FDA approves Glucophage XR 750 mg tabletsCV Therapeutics, Inc. - Net loss of $0.75 per share reported by drug development companyCanji Inc. - Multiple cycles of p53 gene therapy may inhibit recurrent ovarian tumorsCelgene Corporation - Fast track status granted for Revimid; agreement signed for AlkeranCellomics, Inc. - Extended Neurite Outgrowth BioApplication releasedCelltech Group plc - New CEO named at U.K. biotech companyCellular Genomics, Inc. - Industry consultant named to key drug development positionChiron Corporation - Phase III trial for meningococcal C vaccine beginsConnetics Corporation - Capello, Hirsch named VPs at dermatology companyCryo-Cell International - 50,000th Cord blood specimen processedCryo-Cell International, Inc. - Interim CEO, president named to lead strategic transformationCryoCath Technologies - Position in strategic surgical ablation market fortified with allianceCutting Edge Information - Analysis says pharma companies must increase local "thought leader" useCutting Edge Information - Pharmaceutical sales reps adapt to new HIPAA guidelinesDanish Cancer Society - The sex ratio among offspring of childhood cancer survivors is unalteredDeltagen, Inc. - Revenue increases 93% for drug discovery companyDynPort Vaccine Co. - Phase I smallpox vaccine clinical trial completedElite Pharmaceuticals - Opioid antagonist product developed for abuse resistanceElite Pharmaceuticals, Inc. - Controlled release product completes phase I bioavailability studyEndocardial Solutions, Inc. - Nigon, Peltier named as directorsEnglyst Carbohydrates Research and Service Ltd. - Glycemic index of cereal products explained by available glucoseEntropin, Inc. - ENT-103 receives positive review from panel of pain expertsFluor Corp. - Large cell culture manufacturing facility to be built in DenmarkFresenius Medical Care - New FX dialyzer proves highly effectiveGalen Holdings PLC - Women's healthcare products portfolio acquired from PfizerGenVec, Inc. - Newly combined company to commercialize cancer, heart disease drugsGeneMax Corp - Director clarifies SEC action, company positionGenmab A/S - Management change announced at biotech company following CFO's resignationGenset Corp. - Gene variation raises riskGenter Inc. - Zinc expands the feasibility of using exocrine glands for gene transferGenzyme Corp. - First quarter yields 30% increase in revenuesGlaxoSmithKline - Discovery of HM74A, target for nicotinic acid, may lead to discovery of drugGlaxoSmithKline - Investor ask pharma company to lower AIDS drug pricesGlaxoSmithKline - Lamotrigine found effective for maintenance treatment of bipolar I disorderGlaxoSmithKline - Prescription drug settlement announced in Medicaid fraud casesHoffmann-La Roche - AIDS groups to pressure big pharma to lower cost of FuzeonI-trax, Inc. - Disease management company reports more than 500% revenue growthIconix Pharmaceuticals - Chemogenomic profiling relationship initiatedImmunomedics, Inc. - Additional patent granted for proprietary treatment of infectious diseaseImmusol - VIT100 enters phase I studyInex Pharmaceuticals - IND filed for topotecan encapsulated in transmembrane carrier systemIngenium Pharmaceuticals AG - INGENOtyping agreement signedIntegrated Health Technologies, Inc. - Name change becomes effective; shares to be listed on AMEXIntrogen Therapeutics - Independent review of anticancer drugs reports initial clinical successesIntrogen Therapeutics, Inc. - INGN 241 combined with radiation shows promise during preclinical testingIntrogen Therapeutics, Inc. - Preclinical drug studies accelerate understanding of MDA-7 gene functionsIsolagen, Inc. - Regulatory approval sought for biologic to repair scars
Janssen Pharmaceutica - Antipsychotic drug risperidone reduces tics in children and adultsJohnson & Johnson - First quarter EPS rose 16.9% on sales increase of 12.3% for pharmaceutical giantJuvaris BioTherapeutics, Inc. - Warner named chief scientific officerKH Barmherzige Bruder - Imaging can help diagnose acute left lower quadrant painKensey Nash Corporation - Biomaterials maker reports 99% increase in net incomeKing Pharmaceuticals - Pharmaceutical company produces documentation for SECLynx Therapeutics, Inc. - Technique produces comprehensive view of transcriptomesMasimo Corp. - Study compares pulse oximeters in congenital heart defect patientsMcNeil Consumer & Specialty Pharmaceuticals - Muscle relaxer Flexeril reaches pharmaciesMedMira Inc. - FDA approves rapid, point-of-care test to detect HIV-1 antibodiesMedamicus, Inc. - Medical products company releases first quarter resultsMedarex, Inc. - Partnership aims to develop fully human therapeutic antibodiesMedical Services International Inc. - Agreement signed to distribute HIV test kit in The CongoMedline Industries, Inc. - First controlled-release, antimicrobial silver hydrogel now available in U.S.Merck Research Laboratories - Integracide A exhibits inhibitory activity against HIV-1 integraseMillennium Pharmaceuticals - Company's first quarter 2003 results impacted by heart and cancer drugsMillennium Pharmaceuticals - Research identifies molecular pathway related to infection-fighting mechanismMojave Therapeutics - Clinical results reported for heat shock protein-based immunotherapyMolecular Engines Laboratories - Study suggests company's gene product could play role in tumor reversionMoore Medical Corp. - Medical products distributor adds executivesNabi Biopharmaceuticals - S. aureus whole cell vaccine technology licensed for use in cowsNastech Pharmaceutical - Development and commercialization rights for intranasal apomorphine reacquiredNeoPharm, Inc. - New preclinical data released for novel liposomal drug formulationsNeothermia Corp. - Cancer diagnostics firm completes venture-backed financing roundNeurome, Inc. - First 3D reconstruction developed of mouse model of AD pathologyNovarex GmbH - New women's condom available at 20,000 German pharmaciesOntogen Corporation - Pyrrolopyrazinedione-based inhibitors of hormone-sensitive lipase discoveredOulu University Hospital - Infliximab may reduce sciatica painOxxon Pharmaccines Ltd. - Therapeutic vaccines firm raises UKP15 million in international funding roundPPD, Inc. - Equity investment supports research on blood recovery therapeutic peptideParadigm Genetics - Biotech company boosts human health unitParexel International Corp. - Outsourcing group buys interest in Asia-Pacific-based contract research companyPfizer Inc. - Diflucan partnership program launched in ZimbabwePfizer Inc. - Patient assistance programs expanded, drug giant announcesPfizer Inc. - World's largest, research-based, pharmaceutical company createdPfizer, Inc. - FTC clears acquisition plans for pharma giantsPharmacia - Report: Pfizer to conduct 'mass layoffs' after takeoverPlanmed Inc. - Breakthrough in mammographic technology announcedPolish Academy Science - Diagnosis of cerebral ischemia in less than 1% of patients did not prove harmfulPossis Medical, Inc. - Clinical study underway for innovative blood-clot removal systemPrana Biotechnology Ltd. - Discovery of beta-amyloid in eyes of AD patients may aid diagnosticsPrecis Therapeutics, Inc. - An in vitro assay can be used as a surrogate for clinical therapeutic challengePrimal, Inc. - Family of G-protein coupled receptor genes definedQuark Biotech, Inc. - Unique method developed for function-based identification of genesRicerca Biosciences, LLC - Biosciences company announces management changeRoche Diagnostics Corp. - Corporation announces major expansion plans for North American headquartersSirna Therapeutics - Company's new focus prompts name changeSleep Solutions, Inc. - Sleep disorders testing firm names new president, directorSmith Micro Software, Inc. - Company to provide video capabilities to new joint ventureSontra Medical Corp. - Initial clinical results on non-invasive continuous monitoring product reportedSt. Jude Children's Research Hospital - St. Jude to manufacture investigative drugs and vaccinesSunTech Medical Instruments - Blood pressure monitoring specialist announces medical advisory board expansionSunTech Medical Instruments - Revolutionary cuff design unveiledTechnical Insights - Membrane separation technology has applications in many industriesTheratechnologies - First quarter 2003 results released by biotech firmTm Bioscience Corp. - Company enlists clinical laboratories for early access programTransgene - Recent review of DNA vaccines publishedUnited Therapeutics Corp. - Long-term therapy with treprostinil improves survivalUniversity of Alberta - Automated quantitative analysis of chest phantom radiographs is developedUniversity of Colorado - Dual acceptance window technique reduces respiratory motion artifactsUniversity of Oslo - Electron microscopy is a useful tool for differential diagnosisV.I. Technologies, Inc. - U.S. patent coverage expanded for pathogen inactivation in red blood cellsValentis, Inc. - Company receives NASDAQ panel decisionVantageMed Corp. - Healthcare information firm announces change in senior managementVascular Solutions, Inc. - Hematologic device company reports first quarter 2003 resultsVasogen, Inc. - Fuster joins scientific advisory board at immune modulation companyViroLogic, Inc. - Phenotypic drug susceptibility data correlate with improved long-term outcomesWatson Pharmaceuticals, Inc. - Web site available for oral contraceptive informationWomen's Capitol Corp. - Company asks to sell morning-after pill without prescriptionWyeth Pharmaceuticals - FDA approves new indication for RapamuneXenova Group plc - Patient dosing begins in Phase IIa trial for anticocaine addiction vaccineXenova Group plc - Phase II study results of vaccine combination releasedZapaq Inc. - Fundamental U.S. patent on tools for discovering memapsin 2 inhibitorsZapaq, Inc. - OMRF gets patent for company researching treatmentaaiPharma Inc. - Acquisition of injectable treatment for severe pain announced
Return to Top of Page
